Breaking News Instant updates and real-time market news.

EXEL

Exelixis

$12.95

-0.23 (-1.75%)

09:09
10/10/16
10/10
09:09
10/10/16
09:09

Exelixis upgraded to Overweight after trial success at Piper Jaffray

Piper Jaffray analyst Edward Tenthoff upgraded Exelixis to Overweight from Neutral after the company reported Phase II CABOSUN data in 157 front-line metastatic Renal Cell Carcinoma patients. The data are "good enough" to file a supplemental new drug application and could drive off-label front-line RCC use, Tenthoff tells investors in a research note. The analyst raised his price target for the shares to $21 from $8.

  • 10

    Oct

  • 10

    Oct

EXEL Exelixis
$12.95

-0.23 (-1.75%)

09/28/16
LEER
09/28/16
NO CHANGE
LEER
Exelixis selloff overdone, says Leerink
09/28/16
LEER
09/28/16
NO CHANGE
LEER
Outperform
Exelixis selloff based on ESMO abstracts overdone, says Leerink
Leerink analyst Michael Schmidt believes Exelixis' selloff following the publication of ESMO poster abstracts is overdone. The analyst notes that abstract includes updated data from a Phase Ib trial evaluating the combination of axitinib with pembrolizumab and appears to have sparked competitive concerns for Exelixis. However, he believes it is highly premature to draw conclusions at this point on the company's Cabometyx' market opportunity or potential in Renal Cell Carcinoma. Schmidt reiterates an Outperform rating on the shares. In afternoon trading, Exelixis' stock has dropped over 15% to $13.12 per share.
10/10/16
LEER
10/10/16
NO CHANGE
LEER
Outperform
Leerink says ESMO raises confidence in potential label expansions at Exelixis
Following several oral and poster presentations this weekend at the ESMO cancer meeting, Leerink analyst Michael Schmidt said he has greater confidence regarding several potential label expansion opportunities for Exelixis' two products, Cabometyx and Cotellic. Cabometyx is "very well positioned" to capture significant market share and consensus expectations for Cotellic are only modest, believes Schmidt, who keeps an Outperform rating on Exelixis shares.
10/10/16
PIPR
10/10/16
UPGRADE
PIPR
Overweight
Exelixis upgraded to Overweight from Neutral at Piper Jaffray

TODAY'S FREE FLY STORIES

BOCH

Bank of Commerce Holdings

$11.05

0.1 (0.91%)

11:01
04/24/17
04/24
11:01
04/24/17
11:01
Hot Stocks
Bank of Commerce Holdings to relocate headquarters to Sacramento from Redding »

Randall S. Eslick,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WHR

Whirlpool

$174.98

3.47 (2.02%)

11:01
04/24/17
04/24
11:01
04/24/17
11:01
Technical Analysis
Whirlpool technical comments before earnings »

The shares have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

SBH

Sally Beauty

$19.27

-0.425 (-2.16%)

, SMRT

Stein Mart

10:57
04/24/17
04/24
10:57
04/24/17
10:57
Hot Stocks
Sally Beauty slides after downgrade as KeyBanc sees 'hairy' retail story »

Shares of Sally Beauty…

SBH

Sally Beauty

$19.27

-0.425 (-2.16%)

SMRT

Stein Mart

ULTA

Ulta Beauty

$279.50

0.77 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BX

Blackstone

$30.35

0.07 (0.23%)

10:56
04/24/17
04/24
10:56
04/24/17
10:56
Options
Blackstone put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:55
04/24/17
04/24
10:55
04/24/17
10:55
General news
Treasury Action: Treasuries were unaffected by Dallas Fed beat »

Treasury Action:…

KURA

Kura Oncology

10:52
04/24/17
04/24
10:52
04/24/17
10:52
Conference/Events
Kura Oncology management to meet with JMP Securities »

Meeting to be held on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

10:50
04/24/17
04/24
10:50
04/24/17
10:50
General news
U.S. Dallas Fed manufacturing index dipped 0.1 point to 16.8 in April »

U.S. Dallas Fed…

DWCH

Datawatch

$9.25

0.85 (10.12%)

10:49
04/24/17
04/24
10:49
04/24/17
10:49
Conference/Events
Datawatch management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

BGG

Briggs & Stratton

$23.94

0.44 (1.87%)

10:46
04/24/17
04/24
10:46
04/24/17
10:46
Conference/Events
Briggs & Stratton management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

10:45
04/24/17
04/24
10:45
04/24/17
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

AKS

AK Steel

$6.93

0.2083 (3.10%)

, STLD

Steel Dynamics

$35.37

0.46 (1.32%)

10:44
04/24/17
04/24
10:44
04/24/17
10:44
Hot Stocks
Analyst upgrades steel stocks on signs of rebounding demand »

Macquarie upgraded…

AKS

AK Steel

$6.93

0.2083 (3.10%)

STLD

Steel Dynamics

$35.37

0.46 (1.32%)

NUE

Nucor

$60.99

0.99 (1.65%)

X

U.S. Steel

$31.14

0.72 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 25

    May

X

U.S. Steel

$31.10

0.68 (2.24%)

10:41
04/24/17
04/24
10:41
04/24/17
10:41
Options
US Steel sees a bullish option play ahead of earnings »

US Steel sees a bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

PZRX

PhaseRx

$1.24

-0.01 (-0.80%)

10:40
04/24/17
04/24
10:40
04/24/17
10:40
Hot Stocks
PhaseRx receives EC orphan medicinal product designation »

PhaseRx's modified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife

$61.20

1.215 (2.03%)

, WGO

Winnebago

$27.00

0.75 (2.86%)

10:38
04/24/17
04/24
10:38
04/24/17
10:38
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

HLF

Herbalife

$61.20

1.215 (2.03%)

WGO

Winnebago

$27.00

0.75 (2.86%)

VC

Visteon

$97.32

0.3 (0.31%)

RGEN

Repligen

$35.06

-0.78 (-2.18%)

RBA

Ritchie Bros.

$31.48

0.74 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 04

    May

  • 05

    May

  • 30

    May

  • 06

    Jun

  • 08

    Jun

DIS

Disney

$114.80

0.36 (0.31%)

, GRPN

Groupon

$3.88

-0.02 (-0.51%)

10:38
04/24/17
04/24
10:38
04/24/17
10:38
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

DIS

Disney

$114.80

0.36 (0.31%)

GRPN

Groupon

$3.88

-0.02 (-0.51%)

GWW

Grainger

$192.42

-2.735 (-1.40%)

BAC

Bank of America

$23.67

0.955 (4.21%)

DFT

DuPont Fabros

$49.76

-1.44 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 03

    May

  • 09

    May

  • 09

    May

  • 31

    May

  • 06

    Jun

  • 19

    Jul

  • 17

    Oct

  • 24

    Jan

SWK

Stanley Black & Decker

$138.17

0.61 (0.44%)

, KEY

KeyCorp

$18.77

0.615 (3.39%)

10:38
04/24/17
04/24
10:38
04/24/17
10:38
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

SWK

Stanley Black & Decker

$138.17

0.61 (0.44%)

KEY

KeyCorp

$18.77

0.615 (3.39%)

SONC

Sonic

$24.91

0.63 (2.59%)

TRV

Travelers

$120.96

1.86 (1.56%)

WING

Wingstop

$28.27

0.175 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 24

    May

  • 31

    May

  • 20

    Jun

B

Barnes Group

$51.83

0.4 (0.78%)

10:37
04/24/17
04/24
10:37
04/24/17
10:37
Downgrade
Barnes Group rating change  »

Barnes Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

KMB

Kimberly-Clark

$129.49

-0.47 (-0.36%)

10:35
04/24/17
04/24
10:35
04/24/17
10:35
Hot Stocks
Kimberly-Clark says 'don't play too much on speculation process' for M&A »

Regarding the current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 31

    May

10:33
04/24/17
04/24
10:33
04/24/17
10:33
General news
Dallas Fed Mfg Survey General Activity Index data reported »

April Dallas Fed Mfg…

AMP

Ameriprise

$132.30

3.86 (3.01%)

10:33
04/24/17
04/24
10:33
04/24/17
10:33
Hot Stocks
Ameriprise announces agreement to acquire Investment Professionals »

Ameriprise Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

BAC

Bank of America

$23.70

0.99 (4.36%)

10:31
04/24/17
04/24
10:31
04/24/17
10:31
Options
Heavy trading in BofA calls as shares rally Monday »

Heavy trading in BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

  • 31

    May

  • 06

    Jun

NBL

Noble Energy

$34.17

0.02 (0.06%)

, CWEI

Clayton Williams

$133.00

0.1 (0.08%)

10:25
04/24/17
04/24
10:25
04/24/17
10:25
Conference/Events
Clayton Williams to host special shareholder meeting »

Special Shareholder…

NBL

Noble Energy

$34.17

0.02 (0.06%)

CWEI

Clayton Williams

$133.00

0.1 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 02

    May

AKTX

Akari Therapeutics

$20.50

4.13 (25.23%)

10:25
04/24/17
04/24
10:25
04/24/17
10:25
Conference/Events
Akari Therapeutics to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

MSFT

Microsoft

$66.40

0.9 (1.37%)

10:21
04/24/17
04/24
10:21
04/24/17
10:21
Options
$4.2M premium block in Microsoft ahead of earnings »

$4.2M premium block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 09

    May

10:20
04/24/17
04/24
10:20
04/24/17
10:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has so…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.